3. As of noon trading, Actavis ( ACT) is up $2.14 (2.16) to $101.03 on average volume Thus far, 795,702 shares of Actavis exchanged hands as compared to its average daily volume of 1.1 million shares. The stock has ranged in price between $99.03-$101.46 after having opened the day at $99.03 as compared to the previous trading day's close of $98.89. Actavis, Inc., an integrated specialty pharmaceutical company, engages in developing, manufacturing, marketing, selling, and distributing generic, branded generic, brand, biosimilar, and over-the-counter pharmaceutical products worldwide. Actavis has a market cap of $12.6 billion and is part of the drugs industry. The company has a P/E ratio of 129.3, above the S&P 500 P/E ratio of 17.7. Shares are up 15.0% year to date as of the close of trading on Thursday. TheStreet Ratings rates Actavis as a buy. The company's strengths can be seen in multiple areas, such as its revenue growth, expanding profit margins and solid stock price performance. We feel these strengths outweigh the fact that the company has had sub par growth in net income. Get the full Actavis Ratings Report now. Exclusive Offer: Jim Cramer's 'go-to' small/mid-cap guru Bryan Ashenberg only buys stocks he thinks could return 50-100%. See his top picks for 14-days FREE.
Watson Pharmaceuticals (NYSE:WPI) is trading at unusually high volume Tuesday with 2.2 million shares changing hands. It is currently at two times its average daily volume and trading up $3.01 (+2.4%).
Watson Pharmaceuticals (NYSE:WPI) hit a new 52-week high Monday as it is currently trading at $127.42, above its previous 52-week high of $126.53 with 1.3 million shares traded as of 9:35 a.m. ET. Average volume has been 1.1 million shares over the past 30 days.
Watson Pharmaceuticals (NYSE:WPI) is trading at unusually high volume Tuesday with 2.8 million shares changing hands. It is currently at 2.7 times its average daily volume and trading up $2.55 (+2.1%).